comparemela.com

Latest Breaking News On - Reporting items - Page 1 : comparemela.com

Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials

Objective We explored the comparative effectiveness of available therapies for chronic pain associated with temporomandibular disorders (TMD). Design Systematic review and network meta-analysis of randomised clinical trials (RCTs). Data sources MEDLINE, EMBASE, CINAHL, CENTRAL, and SCOPUS were searched to May 2021, and again in January 2023. Study selection Interventional RCTs that enrolled patients presenting with chronic pain associated with TMD. Data extraction and synthesis Pairs of reviewers independently identified eligible studies, extracted data, and assessed risk of bias. We captured all reported patient-important outcomes, including pain relief, physical functioning, emotional functioning, role functioning, social functioning, sleep quality, and adverse events. We conducted frequentist network meta-analyses to summarise the evidence and used the GRADE approach to rate the certainty of evidence and categorise interventions from most to least beneficial. Results 233 trials

Nut consumption linked to improved male fertility, systematic review reveals

A systematic review finds that consuming at least 60 grams of nuts daily significantly enhances male fertility by improving sperm vitality, motility, and morphology, while evidence for nut consumption's impact on female fertility remains limited.

Extensive European study finds very high rates of long-COVID

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

As cannabidiol (CBD) use rises, high quality randomized clinical trials are needed to determine if anti-inflammatory benefits of CBD for heart disease seen in preclinical data will work in a real-world setting, according to research presented at ACC Latin America 2022 Together with CardioAcademic.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.